Michael Barbella, Managing Editor11.20.21
A pair of acquisitions and a (potential) new FDA chief vied for readers' attention this week, as President Joe Biden continued to move his domestic agenda forward. The President kicked off the week by announcing plans to nominate Dr. Robert Cardiff as FDA commissioner, to succeed Dr. Janet Woodcock, who has led the agency for the past year. Califf was commissioner from 2016-2017; he would bring nearly four decades of experience as a doctor, researcher, leader and public servant to the position.
Twenty-four hours after Biden's announcement, Resonetics heralded its 10th acquisition in the last five years, proclaiming its buyout of Hudson Medical Innovations from Preco Inc. Founded in 2012, Hudson Medical manufactures microfluidics, point-of-care diagnostics, biosensors, and advanced wound care devices. The Resonetics deal was followed by Labcorp's second investment this year. The Burlington, N.C.-based company bolstered its testing capabilities by purchasing contract research organization Toxikon, which provides nonclinical testing services for pharmaceutical, biotech and medical technology firms.
Readers also learned about the cybersecurity challenges medtech organizations faced in 2021 and the significant threat cybercriminals pose to the industry (and overall healthcare).
1. Labcorp to Buy Toxikon, a Nonclinical Testing CRO
2. FDA Oks Medtronic's PillCam Small Bowel 3 @HOME Endoscopy
3. Resonetics Acquires Hudson Medical Innovations from Preco
4. Ransomware Attacks Push Cybersecurity Into the Spotlight—2021 Year in Review
5. President Biden to Nominate Dr. Robert Califf for Commissioner of Food and Drugs
Twenty-four hours after Biden's announcement, Resonetics heralded its 10th acquisition in the last five years, proclaiming its buyout of Hudson Medical Innovations from Preco Inc. Founded in 2012, Hudson Medical manufactures microfluidics, point-of-care diagnostics, biosensors, and advanced wound care devices. The Resonetics deal was followed by Labcorp's second investment this year. The Burlington, N.C.-based company bolstered its testing capabilities by purchasing contract research organization Toxikon, which provides nonclinical testing services for pharmaceutical, biotech and medical technology firms.
Readers also learned about the cybersecurity challenges medtech organizations faced in 2021 and the significant threat cybercriminals pose to the industry (and overall healthcare).
1. Labcorp to Buy Toxikon, a Nonclinical Testing CRO
2. FDA Oks Medtronic's PillCam Small Bowel 3 @HOME Endoscopy
3. Resonetics Acquires Hudson Medical Innovations from Preco
4. Ransomware Attacks Push Cybersecurity Into the Spotlight—2021 Year in Review
5. President Biden to Nominate Dr. Robert Califf for Commissioner of Food and Drugs